Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors

by Helena Norberg, Ellinor Bergdahl, Krister Lindmark
Published 2019-01-01

Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal function.

by Anna Jonsson Holmdahl, Helena Norberg, Fredrik Valham, Ellinor Bergdahl, Krister Lindmark
Published 2021-01-01

Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal function

by Anna Jonsson Holmdahl, Helena Norberg, Fredrik Valham, Ellinor Bergdahl, Krister Lindmark
Published 2021-01-01

Comparison of creatinine‐based methods for estimating glomerular filtration rate in patients with heart failure

by Anna Jonsson, Ida Viklund, Andreas Jonsson, Fredrik Valham, Ellinor Bergdahl, Krister Lindmark, Helena Norberg
Published 2020-06-01

Motives, frequency, predictors and outcomes of MRA discontinuation in a real-world heart failure population

by Krister Lindmark, Anna Jonsson Holmdahl, Gustav Wessberg, Helena Norberg, Adrian Söderström, Fredrik Valham, Ellinor Bergdahl
Published 2022-08-01

Diabetes status-related differences in risk factors and mediators of heart failure in the general population: results from the MORGAM/BiomarCaRE consortium

by Matti A. Vuori, Jaakko Reinikainen, Stefan Söderberg, Ellinor Bergdahl, Pekka Jousilahti, Hugh Tunstall-Pedoe, Tanja Zeller, Dirk Westermann, Susana Sans, Allan Linneberg, Licia Iacoviello, Simona Costanzo, Veikko Salomaa, Stefan Blankenberg, Kari Kuulasmaa, Teemu J. Niiranen
Published 2021-09-01